Insulet (PODD) Research & Development (2010 - 2026)

Insulet has reported Research & Development for 17 years, with the latest figure at $89.7 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 50.5% year-over-year to $89.7 million; the trailing twelve-month figure through Mar 2026 stood at $331.2 million (up 44.63% YoY), and the FY2025 full-year result was $301.1 million, up 37.11% from the prior year.
• Research & Development for Q1 2026 stood at $89.7 million, down from $90.9 million in the prior quarter.
• The five-year high for Research & Development was $90.9 million in Q4 2025, with the low at $42.0 million in Q4 2023.
• Historically, Research & Development has averaged $58.6 million across 5 years, with a median of $54.9 million in 2024.
• Annual changes were most pronounced in 2023 — Research & Development retreated 15.15% — and 2026, when it surged 50.5%.
• Insulet's Research & Development stood at $49.5 million in 2022, then declined by 15.15% to $42.0 million in 2023, then surged by 44.29% to $60.6 million in 2024, then jumped by 50.0% to $90.9 million in 2025, then declined by 1.32% to $89.7 million in 2026.
• The last three Research & Development figures came in at $89.7 million (Q1 2026), $90.9 million (Q4 2025), and $77.2 million (Q3 2025), per Business Quant data.